Understanding Comorbid Substance Use Disorders and Serious Mental Illness-View Presentation Slides

View Presentation Slides

Pdf Summary

The provided document is a comprehensive webinar presentation by the American Psychiatric Association, focused on understanding comorbid substance use disorders (SUD) and serious mental illness (SMI). The presentation includes details on continuing education credits, providing a thorough discussion on the definition, prevalence, treatment, and management of SUDs and their coexistence with mental illness.<br /><br />Key points include the prevalence rates in the US, highlighting that millions experience both SUDs and SMIs. A significant percentage of these individuals do not receive treatment, underscoring the need for increased medical and therapeutic intervention.<br /><br />The presentation defines addiction per the American Society of Addiction Medicine, describing it as a chronic disease with psychological, social, and spiritual dimensions, often involving cycles of relapse and remission. Substance use disorders encompass a range of drugs that activate the brain's reward system, potentially leading to social, occupational, and physical impairments.<br /><br />The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for diagnosing SUDs is detailed, adopting a spectrum approach from mild to severe across various substances. This comprehensive approach facilitates personalization of treatment plans.<br /><br />Strategies for combating SUDs are detailed through motivational interviewing and medication-assisted treatments (MAT), including options like buprenorphine, methadone, and naltrexone, which are often combined with behavioral therapies.<br /><br />The webinar emphasizes the critical role of medical professionals in screening, referral, and treatment of SUDs, highlighting the importance of treating SUDs as chronic diseases to improve recovery rates and reduce relapse incidence. Finally, it advocates destigmatization of SUD treatment by consistently framing addiction as a medical condition rather than a moral failing.<br /><br />The webinar also offers multiple resources for further learning and future webinars, and concludes by encouraging a question-and-answer session to enhance understanding and knowledge sharing among professionals.

Keywords

comorbid substance use disorders

serious mental illness

American Psychiatric Association

addiction treatment

DSM-5 criteria

medication-assisted treatment

motivational interviewing

destigmatization

continuing education

medical professionals